+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

High-Density Multiplexed Diagnostic Assays - Global Strategic Business Report

  • PDF Icon

    Report

  • 158 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139838

Global High-Density Multiplexed Diagnostic Assays Market to Reach $4.9 Billion by 2030

The global market for High-Density Multiplexed Diagnostic Assays estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$4.9 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2022-2030. Diagnostic Laboratories, one of the segments analyzed in the report, is projected to record 15.2% CAGR and reach US$1.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Hospitals & Clinics segment is readjusted to a revised 14.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $474 Million, While China is Forecast to Grow at 13.8% CAGR

The High-Density Multiplexed Diagnostic Assays market in the U.S. is estimated at US$474 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$819.1 Million by the year 2030 trailing a CAGR of 13.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.5% and 12.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.5% CAGR.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Erba Diagnostics, Inc.
  • F. Hoffmann-La Roche AG
  • Gold Standard Diagnostics Corporation
  • Hologic, Inc.
  • Luminex Corporation
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific, Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • High-density Multiplexed Diagnostic Assays - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World High-Density Multiplexed Diagnostic Assays Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 3: World Historic Review for High-Density Multiplexed Diagnostic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 4: World 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 6: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 7: World 16-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 9: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 10: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 11: USA Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 12: USA Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 13: USA 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
CANADA
  • Table 14: Canada Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 15: Canada Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 16: Canada 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
JAPAN
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 17: Japan Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 18: Japan Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 19: Japan 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
CHINA
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 20: China Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 21: China Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 22: China 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
EUROPE
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 23: Europe Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 24: Europe Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 25: Europe 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
  • Table 26: Europe Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 27: Europe Historic Review for High-Density Multiplexed Diagnostic Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 28: Europe 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
FRANCE
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 29: France Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 30: France Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 31: France 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
GERMANY
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 32: Germany Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: Germany Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 34: Germany 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
ITALY
  • Table 35: Italy Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 36: Italy Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 37: Italy 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 38: UK Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: UK Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 40: UK 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 41: Rest of Europe Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 42: Rest of Europe Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 43: Rest of Europe 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • High-Density Multiplexed Diagnostic Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 44: Asia-Pacific Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 45: Asia-Pacific Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 46: Asia-Pacific 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
REST OF WORLD
  • Table 47: Rest of World Recent Past, Current & Future Analysis for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 48: Rest of World Historic Review for High-Density Multiplexed Diagnostic Assays by End-Use - Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 49: Rest of World 16-Year Perspective for High-Density Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown of Value Sales for Diagnostic Laboratories and Hospitals & Clinics for the Years 2014, 2023 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Erba Diagnostics, Inc.
  • F. Hoffmann-La Roche AG
  • Gold Standard Diagnostics Corporation
  • Hologic, Inc.
  • Luminex Corporation
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific, Inc.

Table Information